WH 504
Alternative Names: WH-504Latest Information Update: 26 Jun 2024
At a glance
- Originator Novan Inc
- Class Antivirals; Nitrogen oxides
- Mechanism of Action Nitric oxide stimulants; Virus replication inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Human papillomavirus infections
Most Recent Events
- 26 Jun 2024 Discontinued - Preclinical for Human papillomavirus infections in USA (Vaginal) (Pelthos Therapeutics pipeline; June 2024)
- 28 Jan 2024 No recent reports of development identified for preclinical development in Human-papillomavirus-infections in USA (Vaginal, Suppository)